Subcellular drug distribution profiling
QTM quantifies and models a drug’s subcellular distribution profile.
Source: LinkedIn company description · Retrieved October 13, 2026
QTM quantifies and models drug subcellular distribution profiles, also referred to as pharmacokinetics 2.0.
QTM has developed a proprietary label-free method to measure bound and unbound cytosolic and organelle drug concentrations.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
QTM provides consulting for molecular PKPD challenges during drug development.
QTM quantifies and models a drug’s subcellular distribution profile.
Source: LinkedIn company description · Retrieved October 13, 2026
QTM simulates subcellular drug distribution.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026, September 19, 2026, September 27, 2026 and September 28, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.